The thymus and the pathogenesis of myasthenia gravis

Clinical Immunology and Immunopathology

Volumn 78, Issue 1, 1996, Pages 1-5

  Levinson, A I ^a   Wheatley, L M ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR; CYTOKINE; HLA DR ANTIGEN; THYMOPOIETIN;

AUTOIMMUNITY; ETIOLOGY; HUMAN; MYASTHENIA GRAVIS; PRIORITY JOURNAL; REVIEW; THYMUS;

EID: 0029988314     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0001     Document Type: Review

References (47)

1. Levinson, A. I., Zweiman, B., and Lisak, R. P., Immunopathogenesis and treatment of myasthenia gravis. J. Clin. Immunol. 7, 187-197, 1987.
2. Hohlfed, R., Toyka, K. V., Tzartos, S. J., Carson, W., and Conti-Tronconi, B. M., Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic a subunit. Proc. Natl. Acad. Sci. USA 84, 5379-5383, 1987.
3. Hohlfeld, R., Toyka, K. V., Miner, L. L., Walgrave, S. L., and Conti-Tronconi, B. M., Amphipathic segment of the nicotinic receptor of the a subunit contains epitopes recognized by T lymphocytes in myasthenia gravis. J. Clin. Invest. 81, 657-660, 1988.
4. Harcourt, G. C., Sommer, N., Rothbard, J., Willcox, H. N. A.,.A., and Newsom-Davis, J., A juxtamembrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis. J. Clin. Invest. 82, 1295-1300, 1988.
5. Brocke, S., Brautbar, C., Steinman, L., Abramsky, O., Rothbard, J., Neumann, D., Fuchs, S., and Mozes, E., In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA Class II genes. J. Clin. Invest. 82, 1894-1900, 1988.
6. Oshima, M., Ashizawa, T., Pollack, M. S., and Atassi, M. Z., Autoimmune T cell recognition of human acetylcholine receptor: The sites of T cell recognition in myasthenia gravis on the extracellular part of the a subunit. Eur. J. Immunol. 20, 2563-2569, 1990.
7. Protti, M. P., Manfredi, A. A., Straub, C., Wu, X., Howard, J. F., Jr., and Conti-Tronconi, B. M., Use of synthetic peptides to establish anti-human acetylcholine receptor CD4+ cell lines from myasthenia gravis patients. J. Immunol. 144, 1711-1720, 1990.
8. Mokthtarian, F., Pino, M., Ofosu-Appiah, W., and Grob, D., Phenotypic and functional characterization of T cells from patients with myasthenia gravis. J. Clin. Invest. 86, 2099-2108, 1990.
9. Castleman, B., and Norris, E. H., The pathology of the thymus gland in myasthenia gravis. Medicine 28, 27-58, 1949.
10. Wekerle, H., and Müller-Hermelink, H. K.,. The thymus in myasthenia gravis. Curr. Topics Pathol. 75, 179-206, 1986.
11. Müller-Hermelink, H. K., Geuder, A. M., and Kirchner, T., The pathological basis of thymoma-associated myasthenia gravis. Ann. N.Y. Acad. Sci. 681, 56-65, 1993.
12. Mokhtar, N. S., Hsu, M., Lad, R. P., Haynes, B. F., and Jaffe, E. S., Thymoma: Lymphoid and epithelial components mirror the phenotype of normal thymus. Hum. Pathol. 15, 378-384, 1984.
13. Olanow, C. W., Wechsler, A. S., Sirotkin-Roses, M., Stajich, J., and Roses, A. D., Thymectomy as primary therapy in myasthenia gravis. Ann. N.Y. Acad. Sci. 505, 595-606, 1987.
14. Grob, D., Arsura, E. L., Brunner, N. G., and Namba, T., The course of myasthenia gravis and therapies affecting outcome. Ann. N.Y. Acad. Sci. 505, 472-499, 1987.
15. Genkins, G., et al., Clinical experience in more than 2000 patients with myasthenia gravis. Ann. N.Y. Acad. Sci. 505, 500-514, 1987.
16. Genkins, G., Sivar, M., and Tartter, P. I.,. Treatment strategies in myasthenia gravis. Ann. N.Y. Acad. Sci. 681, 603-608, 1993.
17. Wheatley, L. M., Urso, D., Zheng, Y., Loh, E., and Levinson, A. I., Molecular analysis of intrathymic nicotinic acetylcholine receptor. Ann. N.Y. Acad. Sci. 681, 74-82, 1993.
18. Wekerle, H., Ketelson, U-P., Zurn, A. D., and Fulpius, B. W., Intrathymic pathogenesis of myasthenia gravis: Transient expression of acetylcholine receptors on thymus-derived myogenic cells. Eur. J. Immunol. 8, 579-582, 1978.
19. Wheatley, L., Urso, D., Tumas, K., Maltzman, J., Loh, E., and Levinson, A. I., Molecular characterization of the nicotinic acetylcholine receptor a chain in mouse thymus. J. Immunol. 148, 3105-3109, 1992.
20. Schluep, M. N., Wilcox, N., Vincent, A., Dhoot, G. K., and Newsome-Davis, J., Acetylcholine in human thymic myoid cells in situ: An immunologic study. Ann. Neurol. 22, 212-222, 1987.
21. Kirchner, T., Tzartos, S., Hoppe, F., Schalke, B., Wekerle, H., and Müller-Hermelink, H. K.,. Pathogenesis of myasthenia gravis, AChR-related determinants in tumor-free thymus and thymic epithelial tumors. Am. J. Pathol. 130, 268-280, 1988.
22. Fuchs, S., Schmidt-Hopfeldd, I., and Tridente, G., Thymic lymphocytes bear a surface antigen which cross-reacts with acetylcholine receptor. Nature 287, 162-164, 1980.
23. Engel, W. K., Trotter, J. L., McFarlin, D. E., and McIntosh, C. L., Thymic epithelial cells contain acetylcholine receptor. Lancet 1, 1310-1311, 1977.
24. Wekerle, H., The thymus in myasthenia. Ann. N.Y. Acad. Sci. 681, 47-55, 1993.
25. Nelson, S., and Conti-Tronconi, B., Adult thymus expresses an embryonic nicotinic acetylcholine receptor-like protein. J. Neuroimmunol. 29, 81-92, 1990.
26. Protti, M. P., Manfredi, A. A., Wu, X., Moiola, L., Howard, J. F., and Conti-Tronconi, B. M., Myasthenia gravis. T cell epitopes on the d subunit of human muscle acetylcholine receptor. J. Immunol. 146, 2253-2261, 1991.
27. Marx, A., O'Connor, R., Geuder, K. I., Hoppe, F., Schalke, B., Szartos, S., Kalies, I., Kirchner, T., and Müller-Hermelink, H. K., Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab. Invest. 62, 279-286, 1990.
28. Mihovilovic, M., and Roses, A., Expression of mRNAs in human thymus coding for the a3 subunit of a neuronal acetylcholine receptor. Exp. Neurol. 111, 175-180, 1991.
29. Geuder, K., Marx, A. I., Witzemann, V., Schalke, B., Toyka, K. V., Kirchner, T., and Müller-Hermelink, H. K., Pathogenetic significance of fetal acetylcholine receptors on thymic myoid cells in myasthenia gravis. Dev. Immunol. 2, 69-75, 1992.
30. Levinson, A. I., Dziarski, A., Lisak, R. P., Zweima, B., Moskovitz, A., Brenner, T., and Abramsky, O., Comparative immunoglobulin synthesis by blood lymphocytes of myasthénies and normals. Ann. N.Y. Acad. Sci 505, 385-391, 1981.
31. Levinson, A. I., Zweiman, B., and Lisak, R. P., Pokeweed mitogen-induced immunoglobulin secretory responses to thymic B cells in myasthenia gravis: Selective secretion of IgG vs IgM cannot be explained by helper functions of thymic T cells. Clin. Immunol. Immunopathol. 57, 211-217, 1990.
32. Newsom-Davis, J., Willcox, N., and Calder, L., Thymus cells in myasthenia gravis selectively enhance production of antiacetylcholine-receptor antibody by autologous blood lymphocytes. N. Engl. J. Med. 305, 1313-1318, 1981.
33. Lisak, R. P., Levinson, A. I., Zweiman, B., and Kornstein, M. J., Antibodies to acetylcholine receptor and tetanus toxoid: In vitro synthesis by thymic lymphocytes. J. Immunol. 137, 1221-1225, 1986.
34. Fujii, Y., Specific activation of lymphocytes against acetylcholine receptor in myasthenia gravis. J. Immunol. 136, 887-891, 1986.
35. Durelli, L., Massaza, U., Poccardi, G., Ferrio, M. F., Cavallo, R., Maggi, G., Cassadio, C., DiSumma, M., and Bergamini, L., Increased thymocyte differentiation in myasthenia gravis. A dual color immunofluorescence phenotypic analysis. Ann Neurol. 27, 174-180, 1990.
36. Fujii, Y., Itoyama, Y., and Goto, I., Increase in differentiated type of T lineage cells in the myasthenic thymus: Two-color fluorometric analysis. Ann. Neural. 27, 642-646, 1990.
37. Melms, A., Schalke, B. C. G.,.G Kirchner, T., Muller-Hermelink, H. K., Albert, E., and Werkele, H., Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotine acetylcholine receptor from thymuses of myasthenic patients. J. Clin. Invest. 81, 902-908, 1988.
38. Sommer, N., Willcox, N., Harcourt, G. C., and Newsome-Davis, J., Myasthenic thymus and thymoma are selectively enriched in AChR-reactive T cells. Neurology 41,1270-1276, 1991.
39. Naparstek, Y., Holoshitz, J., Eisenstein, S., Rappaport, S., Chemke, J., Ben-Nun, A., and Cohen, I. R., Effector T lymphocyte cell line cells migrate to the thymus and persist there. Nature 300, 262-264, 1982.
40. Emilie, D., Devergne, O., Cohen-Kaminsky, S., Berrih-Aknin, S., and Galanaud, P., In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients. Ann. N.Y. Acad. Sci. 681, 100-102, 1993.
41. Emilie, D., Creron, M. C., Cohen-Kaminsky, S., Peuchmaur, M., Devergne, O., Berrih-Aknin, S., and Galanaud, P., In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients. Hum. Pathol. 22, 461-468, 1991.
42. Hirano, T., Akira, S., Taga, T., and Kishimoto, T., Biological and clinical aspects of interleukin 6. Immunol. Today 11, 443-449, 1990.
43. Meinl, E., Klinkert, W. E. F.,.F., and Wekerle, H., The thymus in MG: Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat. Am. J. Pathol. 139, 995-1008, 1991.
44. Morgutti, M., Conti-Tronconi, B., Sghirlanzoni, A., and Clementi, F., Cellular immune response to acetylcholine receptor in myasthenia gravis. II. Thymectomy and corticosteroids. Neurology 29, 734-738, 1979.
45. Eymard, B., Aime, C., Cottin, C., Morel, E., Goldstein, G., Bach, J. F., and Berrih Aknin, S., Combined effects of a thymic peptide, thymopoeitin, and myasthenic patient sera in a rat myotube culture. J. Neurol. Sci. 112, 216-221, 1992.
46. Goldstein, G., Aime, C., Berrih Aknin, S., Cottin, C., Eymard, B., Bach, J. F., and Morel, E., Retraction of Eymard, B., Aime, C., Cottin, C., Morel, E., Goldstein, G., Bach, J.F., and Berrih Aknin, S. J. Neurol. Sci. 112, 216-221, 1992. J. Neural. Sci. 120, 120, 1993.
47. Goldstein, G., Aime, C., Berrih Aknin, S., Cottin, C., Eymard, B., Bach, J. F., and Morel, E., Retraction of Eymard, B., Aime, C., Cottin, C., Morel, E., Goldstein, G., Bach, J.F., and Berrih Aknin, S. J. Neurol. Sci. 112, 216-221, 1992. J. Neural. Sci. 120, 120, 1993.